PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.

Tarih
2011
Yazar
Flinn, I. W.
Leonard, J.
Reeves, J.
Ferhanoglu, B.
Doner, K. T.
Eom, H.
Raposo, J.
Chowhan, N. M.
Suh, C.
Noga, S.
Tumyan, G.
Aung, S.
Hajdenberg, J.
Ulrich, B. K.
Pendergrass, K. B.
Mulligan, G.
Rizo, A.
Kussick, S.
Offner, F.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/142378
https://doi.org/10.1200/jco.2011.29.15_suppl.tps226
Koleksiyonlar